More on MET

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+106.5% Growth)
- Ratings (5.0 Score)
- Holders
- Dividends (2.8% Yield)
- Event Driven Deals

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (2/2/17 *Est.)
- Spin-Off (N/A)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

MET Balance Sheet

Click line-items for a historical chart and %
Investments:
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $330,903 and $317,617, respectively; includes $3,357 and $3,330, respectively, relating to variable interest entities) 390.44B
Equity securities available-for-sale, at estimated fair value (cost: $3,128 and $3,621, respectively) 3.29B
Trading and other securities, at estimated fair value (includes $560 and $463, respectively, of actively traded securities; and $359 and $387, respectively, relating to variable interest entities)
Mortgage loans:
Held-for-investment, principally at amortized cost (net of valuation allowances of $566 and $664, respectively; includes $6,697 and $6,840, respectively, at estimated fair value, relating to variable interest entities)
Held-for-sale, principally at estimated fair value
Mortgage loans, net 71.16B
Policy loans 11.18B
Real estate and real estate joint ventures (includes $15 and $10, respectively, relating to variable interest entities)
Other limited partnership interests (includes $331 and $298, respectively, relating to variable interest entities) 6.88B
Short-term investments, principally at estimated fair value 11.66B
Other invested assets, principally at estimated fair value (includes $98 and $104, respectively, relating to variable interest entities) 30.28B
Total investments 548.79B
Cash and cash equivalents, principally at estimated fair value (includes $65 and $69, respectively, relating to variable interest entities) 15.88B
Accrued investment income (includes $34 and $34, respectively, relating to variable interest entities) 4.2B
Premiums, reinsurance and other receivables (includes $2 and $2, respectively, relating to variable interest entities) 26.18B
Deferred policy acquisition costs and value of business acquired 24.75B
Goodwill 9.59B
Other assets (includes $7 and $6, respectively, relating to variable interest entities) 7.87B
Assets of subsidiaries held-for-sale
Separate account assets 315.65B
Total assets 952.9B
Liabilities
Future policy benefits 208.56B
Policyholder account balances 216.19B
Other policy-related balances 14.86B
Policyholder dividends payable 763M
Policyholder dividend obligation 3.35B
Payables for collateral under securities loaned and other transactions
Bank deposits
Short-term debt 201M
Long-term debt (includes $6,569 and $6,902, respectively, at estimated fair value, relating to variable interest entities)
Collateral financing arrangements 4.08B
Junior subordinated debt securities 3.17B
Current income tax payable 151M
Deferred income tax liability
Other liabilities (includes $82 and $93, respectively, relating to variable interest entities) 32.13B
Liabilities of subsidiaries held-for-sale
Separate account liabilities 315.65B
Total liabilities 874.44B
Contingencies, Commitments and Guarantees (Note 8)
Redeemable noncontrolling interests in partially owned consolidated subsidiaries
MetLife, Inc.'s stockholders' equity:
Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 1,060,584,995 and 989,031,704 shares issued at June 30, 2011 and December 31, 2010, respectively; 1,057,391,108 and 985,837,817 shares outstanding at June 30, 2011 and December 31, 2010, respectively 12M
Additional paid-in capital 30.8B
Retained earnings 37.05B
Treasury stock, at cost; 3,193,887 shares at June 30, 2011 and December 31, 2010 -3.17B
Accumulated other comprehensive income (loss) 13.6B
Total MetLife, Inc.'s stockholders' equity 78.29B
Noncontrolling interests 180M
Total equity 78.47B
Total liabilities and equity 952.9B
Noncumulative Preferred Stock
MetLife, Inc.'s stockholders' equity:
Preferred Stock 0
Total equity
Convertible Preferred Stock
MetLife, Inc.'s stockholders' equity:
Preferred Stock
Total equity